Market news

IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights...

Elevara Medicines Appoints Biotech Veteran as CEO Founder and former CEO of Nasdaq listed IO Biotech, Dr Mai-Britt Zocca appointed CEOExperienced chief executive with extensive operational and strategic experience in the international biotechnology sector Emma Tinsley to step down as CEO and become a Non-Executive Director on the Board London, UK – 14 July 2026 – Elevara Medicines (“Elevara”), a clinical-stage biotech developing therapies for rheumatoid arthritis (“RA”) and other chronic inflamm